Price Band
₹51 - ₹54
Lot Size
2000
Issue Size
₹22.31 Cr
GMP
N/A
Subscription
1.83x
IPO Schedule
Open
10 Sept 2025
Close
12 Sept 2025
Allotment
15 Sept 2025
Listing
17 Sept 2025
About Galaxy Medicare Ltd
Galaxy Medicare Ltd is an SME focused on [Insert accurate description of Galaxy Medicare's business here, e.g., manufacturing and marketing pharmaceutical formulations and nutraceutical products]. They cater to [Insert target market details, e.g., domestic and international markets] through [Mention distribution channels, e.g., direct sales and distributor networks].
Key Strengths
- Strong ROE of 19.88% indicating efficient profitability.
- Reasonable P/E ratio of 19.01 compared to industry peers (Requires industry benchmark for confirmation).
- [Insert strength specific to Galaxy Medicare, e.g., Established distribution network in key regions].
- [Insert strength specific to Galaxy Medicare, e.g., Diversified product portfolio catering to various therapeutic segments].
- [Insert strength specific to Galaxy Medicare, e.g., Experienced management team with a proven track record].
Risk Factors
- •SME IPOs are generally associated with higher volatility and liquidity risk.
- •[Insert risk specific to Galaxy Medicare, e.g., Dependence on key suppliers for raw materials].
- •[Insert risk specific to Galaxy Medicare, e.g., Intense competition from established pharmaceutical companies].
Valuation Analysis
At the upper price band of ₹54, the IPO appears reasonably valued considering the company's ROE and P/E ratio, but a thorough comparison with industry peers is crucial for a comprehensive assessment. Investors should carefully consider the associated risks of investing in an SME IPO.
IPO Details
Key Metrics
Growth & Quality
Subscription
Documents
Registrar
CAMEO